Admission into the Aurobindo Pharma foundation - Skill Development Center at Hyderabad for ARP & ALP Programme
1 Auro Royal Program (ARP) is a skill Enhancement training program for the M.Sc. and B. Pharma students in the domains of QC/QA/ARD/FARD/Stability functions applicable in both Formulation and API verticals.
Qualification: B. Pharmacy / M. Sc. (Org., Inorganic & Analytical Chemistry)
Year of Passing: 2021, 2022, 2023 & 2024 (Passed outs) Study Stipend: Rs. 15,000/- per month, Program duration: 4 Months
2 Auro Loyal Program (ALP) is specially designed to groom the Diploma and ITI students for Production and Packaging requirements for Formulation vertical.
Qualification: Diploma / ITI
Year of Passing: 2021, 2022, 2023 & 2024 (Passed outs)
Study Stipend: Rs. 8,000/- & 5000/- per month, Program duration: 3 Months
Other Benefits:
Free Bus Transportation facility from Kukatpally to SDC & Subsidized canteen facility.
Walk-In-Interview Date : 12th July 2024
Time : 09:00 AM to 10:30 AM
Venue : APL Research Center-II, Survey No. 71&72, Pashamylaram, Sanga Reddy Dist., Telangana.
Walk-In-Interview Date : 21st July 2024
Time : 09:00 AM to 10:30 AM
Venue : APL Research Center-I (Aurobindo Pharma Unit - III), Survey No. 313&314, Bachupally, Miyapur, Telangana
Aurobindo Pharma was established in 1986 as a result of a vision shared by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy, and a select group of devoted experts. The business started in 1988 &1989 with a single unit in Pondicherry producing semi-synthetic penicillin (SSP). In 1992, Aurobindo Pharma went public, and in 1995, it floated its shares on the Indian stock exchanges. In addition to dominating the semi-synthetic penicillin industry, it also has a presence in important therapeutic areas like gastroenterology, neurosciences, cardiology, anti-retrovirals, anti-diabetics, and antibiotics, among others. By consistently conducting research, developing, and manufacturing a wide range of pharmaceutical products that adhere to the highest regulatory standards, Aurobindo aims to become the most valued Pharma partner to the tin global pharmaceutical community.
Aurobindo Pharma, one of the biggest R&D institutions in India, has five research centers spanning 16,000 square meters. Additionally, it maintains 3 R&D facilities in the United States. The company's in-house product development skills and over 1700 scientists & analysts provide a speedy turnaround.